Global cardiovascular device innovation: Japan-USA synergies - Harmonization by doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions

Takahiro Uchida, Fumiaki Ikeno, Koji Ikeda, Yuka Suzuki, Koji Todaka, Hiroyoshi Yokoi, Gary Thompson, Mitchel Krucoff, Shigeru Saito

研究成果: ジャーナルへの寄稿記事

13 引用 (Scopus)

抄録

Background: Global medical devices have become more popular, but investment money for medical device development is not easily available in the market. Worldwide health-care budget constraints mean that efficient medical device development has become essential. To achieve efficient development, globalization is a key to success. Spending large amounts of money in different regions for medical device development is no longer feasible. Methods and Results: In order to streamline processes of global medical device development, an academic, governmental, and industrial consortium, called the Harmonization by Doing program, has been set up. The program has been operating between Japan and the USA since 2003. The program has 4 working groups: (1) Global Cardiovascular Device Trials; (2) Study on Post-Market Registry; (3) Clinical Trials; and (4) Infrastructure and Methodology Regulatory Convergence and Communication. Each working group has as its goals the achievement of speedy and efficient medical device development in Japan and the USA. The program has held multiple international meetings to deal with obstacles against efficient medical device development. Conclusions: This kind of program is very important to deliver novel medical devices. Involvement of physicians in this type of activity is also very helpful to achieve these goals.

元の言語英語
ページ(範囲)1714-1718
ページ数5
ジャーナルCirculation Journal
77
発行部数7
DOI
出版物ステータス出版済み - 7 1 2013
外部発表Yes

Fingerprint

Industry
Japan
Equipment and Supplies
Internationality
Budgets
Registries
Communication
Clinical Trials
Delivery of Health Care
Physicians

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

これを引用

Global cardiovascular device innovation : Japan-USA synergies - Harmonization by doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions. / Uchida, Takahiro; Ikeno, Fumiaki; Ikeda, Koji; Suzuki, Yuka; Todaka, Koji; Yokoi, Hiroyoshi; Thompson, Gary; Krucoff, Mitchel; Saito, Shigeru.

:: Circulation Journal, 巻 77, 番号 7, 01.07.2013, p. 1714-1718.

研究成果: ジャーナルへの寄稿記事

Uchida, Takahiro ; Ikeno, Fumiaki ; Ikeda, Koji ; Suzuki, Yuka ; Todaka, Koji ; Yokoi, Hiroyoshi ; Thompson, Gary ; Krucoff, Mitchel ; Saito, Shigeru. / Global cardiovascular device innovation : Japan-USA synergies - Harmonization by doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions. :: Circulation Journal. 2013 ; 巻 77, 番号 7. pp. 1714-1718.
@article{f9e27eb101e54f9abc5c282c4b99f820,
title = "Global cardiovascular device innovation: Japan-USA synergies - Harmonization by doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions",
abstract = "Background: Global medical devices have become more popular, but investment money for medical device development is not easily available in the market. Worldwide health-care budget constraints mean that efficient medical device development has become essential. To achieve efficient development, globalization is a key to success. Spending large amounts of money in different regions for medical device development is no longer feasible. Methods and Results: In order to streamline processes of global medical device development, an academic, governmental, and industrial consortium, called the Harmonization by Doing program, has been set up. The program has been operating between Japan and the USA since 2003. The program has 4 working groups: (1) Global Cardiovascular Device Trials; (2) Study on Post-Market Registry; (3) Clinical Trials; and (4) Infrastructure and Methodology Regulatory Convergence and Communication. Each working group has as its goals the achievement of speedy and efficient medical device development in Japan and the USA. The program has held multiple international meetings to deal with obstacles against efficient medical device development. Conclusions: This kind of program is very important to deliver novel medical devices. Involvement of physicians in this type of activity is also very helpful to achieve these goals.",
author = "Takahiro Uchida and Fumiaki Ikeno and Koji Ikeda and Yuka Suzuki and Koji Todaka and Hiroyoshi Yokoi and Gary Thompson and Mitchel Krucoff and Shigeru Saito",
year = "2013",
month = "7",
day = "1",
doi = "10.1253/circj.CJ-12-1431",
language = "English",
volume = "77",
pages = "1714--1718",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "7",

}

TY - JOUR

T1 - Global cardiovascular device innovation

T2 - Japan-USA synergies - Harmonization by doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions

AU - Uchida, Takahiro

AU - Ikeno, Fumiaki

AU - Ikeda, Koji

AU - Suzuki, Yuka

AU - Todaka, Koji

AU - Yokoi, Hiroyoshi

AU - Thompson, Gary

AU - Krucoff, Mitchel

AU - Saito, Shigeru

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Background: Global medical devices have become more popular, but investment money for medical device development is not easily available in the market. Worldwide health-care budget constraints mean that efficient medical device development has become essential. To achieve efficient development, globalization is a key to success. Spending large amounts of money in different regions for medical device development is no longer feasible. Methods and Results: In order to streamline processes of global medical device development, an academic, governmental, and industrial consortium, called the Harmonization by Doing program, has been set up. The program has been operating between Japan and the USA since 2003. The program has 4 working groups: (1) Global Cardiovascular Device Trials; (2) Study on Post-Market Registry; (3) Clinical Trials; and (4) Infrastructure and Methodology Regulatory Convergence and Communication. Each working group has as its goals the achievement of speedy and efficient medical device development in Japan and the USA. The program has held multiple international meetings to deal with obstacles against efficient medical device development. Conclusions: This kind of program is very important to deliver novel medical devices. Involvement of physicians in this type of activity is also very helpful to achieve these goals.

AB - Background: Global medical devices have become more popular, but investment money for medical device development is not easily available in the market. Worldwide health-care budget constraints mean that efficient medical device development has become essential. To achieve efficient development, globalization is a key to success. Spending large amounts of money in different regions for medical device development is no longer feasible. Methods and Results: In order to streamline processes of global medical device development, an academic, governmental, and industrial consortium, called the Harmonization by Doing program, has been set up. The program has been operating between Japan and the USA since 2003. The program has 4 working groups: (1) Global Cardiovascular Device Trials; (2) Study on Post-Market Registry; (3) Clinical Trials; and (4) Infrastructure and Methodology Regulatory Convergence and Communication. Each working group has as its goals the achievement of speedy and efficient medical device development in Japan and the USA. The program has held multiple international meetings to deal with obstacles against efficient medical device development. Conclusions: This kind of program is very important to deliver novel medical devices. Involvement of physicians in this type of activity is also very helpful to achieve these goals.

UR - http://www.scopus.com/inward/record.url?scp=84879398247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879398247&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-12-1431

DO - 10.1253/circj.CJ-12-1431

M3 - Article

C2 - 23538483

AN - SCOPUS:84879398247

VL - 77

SP - 1714

EP - 1718

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 7

ER -